Press Releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Aug 24, 2015
Boston Scientific Corporation (NYSE: BSX) has received CE Mark on magnetic resonance imaging (MRI) conditional labeling for the current family of EL (Extended Longevity) and MINI implantable...
-
Aug 24, 2015L’aggiornamento della documentazione consente la compatibilità retroattiva con le scansioni MRI per i sistemi ICD e CRT-D a più lunga durata del settore
Boston Scientific Corporation (NYSE: BSX) ha ricevuto il marchio CE per la compatibilità con la risonanza magnetica per immagini (MRI) per le attuali famiglie di sistemi di defibrillatori...
-
Aug 24, 2015Die aktualisierte Indikation gewährleistet eine rückwirkende MRT-Kompatibilität der seit langem etablierten ICD- und CRT-D-Systeme
Die Boston Scientific Corporation (NYSE: BSX) hat das CE-Zeichnen für die MRT-Tauglichkeit der aktuellen implantierbaren EL- und MINI-Kardioverter-Defibrillatoren (ICD) sowie für die...
-
Aug 24, 2015La denominación actualizada permite la retrocompatibilidad con las pruebas de RM de los sistemas de DCI y CRT-D más duraderos del sector
Boston Scientific Corporation (NYSE: BSX) ha recibido el marcado CE para su familia actual de desfibriladores cardioversores implantables (DCI) de larga duración (EL) y MINI, y del desfibrilador...
-
Aug 4, 2015
Boston Scientific Corporation (NYSE: BSX) has closed on the previously announced agreement with Endo International plc (NASDAQ: ENDP) (TSX: ENL) to purchase the American Medical Systems (AMS)...
-
Aug 4, 2015
Boston Scientific Corporation (NYSE: BSX) ha cerrado el acuerdo, previamente anunciado, con Endo International plc (NASDAQ: ENDP) (TSX: ENL) para la adquisición del negocio de andrología y salud...
-
Jul 22, 2015
First Guidewire Designed Specifically for TAVI/R Now Sized for Smaller Ventricles Boston Scientific (NYSE: BSX) announces CE Mark and FDA clearance for the Safari2™ Pre-Shaped Guidewire, a new...
-
Jun 23, 2015The new generation of subcutaneous defibrillators selected as most innovative in the field of cardiac electrophysiology.
MILAN, Italy, June 23, 2014 – Attendees of EHRA EUROPACE-CARDIOSTIM 2015, a global medical conference held recently in Milan, Italy, have selected the EMBLEM™ S-ICD System as the most...
-
Jun 23, 2015
Die Teilnehmer der EHRA EUROPACE-CARDIOSTIM 2015, einer globalen Konferenz, die kürzlich in Mailand stattfand, haben das EMBLEM™-S-ICD-System zum innovativsten Produkt zur Verbesserung der...
-
Jun 22, 2015
Boston Scientific (NYSE: BSX) has initiated a worldwide study to evaluate the rate and causes of shocks for patients implanted with the EMBLEM™ Subcutaneous Implantable Defibrillator (S-ICD) for...